Navigation Links
Bode Technology Reaches Sales Milestone of DNA Collectors

LORTON, Va., July 31, 2013 /PRNewswire/ -- The Bode Technology Group, Inc. (Bode), a leading provider of forensic DNA products and services, announced it has reached significant milestones in sales of its two patented DNA collection systems. The company has sold over 5,000,000 Buccal DNA Collector™ and SecurSwab™ evidence collection products.  Bode's innovative DNA collection systems are designed to improve the efficiency, reliability, and security of the collection and processing of evidence and biological samples from individuals and crime scenes.

"As a forensic DNA crime laboratory, we know that the quality and integrity of DNA evidence can make-or-break solving a case. Reliable collection devices not only improve the chances of obtaining a DNA profile, but also enable efficiency in the laboratory," said Mike Cariola, CEO and President of Bode. "In today's financial environment, streamlined lab operations are critical to the success of a forensic DNA crime lab."

Bode's DNA collection systems have been adopted worldwide for use in DNA databasing programs, most recently in Southeast Asia and for casework programs at Los Angeles Sheriff's Department and the New York Police Department. These innovative and proprietary collection devices are shown to improve DNA collection.  Recently, the National Forensic Science Technology Center (NFSTC) published a study showing the SecurSwab DUO-V had the best DNA recovery of all swabs evaluated.  It collected the most DNA and has features that prevent contamination and reduces possible degradation.

A company White Paper evaluating the efficiency of the Bode Buccal DNA Collector proves that use of the direct collection system reduces cost, processing time, re-run and re-collection rates, saving money for crime laboratories. 

"Bode continues to seek improvement in DNA technologies, from collection devices through processing methods in the laboratory.  When developing collection products, we create a system that includes collection, chain-of-custody control, sample protection and sample storage.  These elements help law enforcement officers and DNA analysts obtain results that can be used to solve crimes," said Andrew Singer, Sr. Product Manager at Bode.  "We do all of this with the highest standards used in the forensic industry."

Bode's collection products are manufactured in an FDA registered facility under cGMP guidelines and clean room conditions.  All DNA collection products are certified to be free of human DNA and DNase.

About The Bode Technology Group, Inc.

Bode Technology provides a comprehensive set of state-of-the-art forensic DNA collection products, analysis services, and research services to law enforcement, justice system, and other government agencies around the world.  Operating one of the most internationally respected private DNA laboratories, Bode's forensic DNA experts have assisted in identifying criminals in every state in the United States, and played a key role in the exoneration of numerous individuals. Bode provides immigration and paternity testing worldwide.  Bode has also been instrumental in the identification of victims of natural disasters, war, crime, and terrorism, including the attack on the World Trade Center. 

Bode Technology is one of the three wholly owned subsidiaries of SolutionPoint International, Inc. (, a leading provider of business intelligence, security, compliance and monitoring, identity assurance, forensics, and situational awareness solutions for the commercial and government sectors.  Through the dedicated focus on excellence of its management teams and employees, SolutionPoint enables its clients to achieve their objectives with the confidence that they can operate in a secure and trusted environment. SolutionPoint is headquartered in New York, NY, and maintains offices and facilities in Washington, D.C.; San Diego, CA; Dallas, TX; Oakland, CA; San Francisco, CA; Chicago, IL; and Lorton, VA. SolutionPoint also operates internationally with an office in London, United Kingdom and a recently opened office in Riyadh, Saudi Arabia.

SOURCE The Bode Technology Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Frost & Sullivan Finds the Entrenched Nature of qPCR Technology Sustains the US Reagents Market
2. RainDrop System Unlocks Power of Trovagenes Urine-Based Mutation Detection Technology
3. HemoShear Co-Founder Presents Recommendations for Funding of Breakthrough Technologies to U.S. House of Representatives Committee on Science, Engineering and Technology
4. Financial Results, Appointments, Earnings Conferences, and Partnerships - Research Report on New Oriental Education & Technology, Acacia Research, DeVry, Capella Education, and Qiagen NV
5. The Galien Foundation Announces 2013 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology"
6. Femtosecond Lasers for Cataract Surgery: Market Shares, Strategies, and Forecasts, Worldwide, Nanotechnology, 2013 to 2018
7. Recent Study Reveals Physicians Prefer Topical Delivery for Drug Delivery Technology, Such as a Transdermal Patch
8. The Centers For Medicare & Medicaid Services (CMS) Draft Decision Could Limit Patient Access To New Technology That May Help In Diagnosing Dementia
9. Abilities Expo -- The Nations Leading Expo for People with Disabilities -- to Feature Push Girls star, Auti Angel, along with an extensive Line Up of New Products, Services and Technology at Reliant Center, August 2-4
10. Craig Hospitals Patients With Brain And Spinal Cord Injuries Now Benefiting From Cutting-Edge Medical Records Exchange Technology
11. Biotechnology Market By Application (Biopharmacy, Bioservices, Bioagri, Bioindustrial), By Technology (Fermentation, Tissue Regeneration, PCR, Nanobiotechnology, DNA Sequencing & Others) - Global Industry Analysis, Size, Share, Growt
Post Your Comments:
(Date:11/27/2015)... 2015  Lannett Company, Inc. (NYSE: LCI ... acquisition of Kremers Urban Pharmaceuticals Inc. (KU), the ... company UCB S.A. (Euronext: UCB). ... KU from UCB for total consideration of approximately ... customary working capital adjustment, a deduction of certain ...
(Date:11/27/2015)... 26, 2015 ... the "2016 Global Tumor Marker Testing ... and Sales Segment Forecasts, Innovative Technologies, Instrumentation ... to their offering. --> ... "2016 Global Tumor Marker Testing Market: ...
(Date:11/26/2015)... Un nuevo enfoque combina la ... cáncer avanzado.   --> Un nuevo ... Bremachlorin para el cáncer avanzado.   --> ... la terapia fotodinámica de Bremachlorin para el cáncer avanzado. ... --> Clinical Cancer Research . --> ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... 2015 , ... An inventor, from Hopkinsville, Ky., thought there ... home, so he invented the patent-pending ELECTRONIC M.D. , The ELECTRONIC M.D. provides ... so, it could help to prevent potential overdose situations. As a result, it ...
(Date:11/27/2015)... Aliso Viejo, CA (PRWEB) , ... November 27, 2015 , ... ... exclusively for use in Final Cut Pro X. With ProSidebar: Fasion, video editors ... banners, or use ProSidebar as a minimalist title opener. Utilize presets featuring self-animating ...
(Date:11/27/2015)... ... November 27, 2015 , ... A simply groundbreaking television ... an interesting show that delves into an array of issues that are presently affecting ... benefit from open dialogue, this show is changing the subjects consumers focus on, one ...
(Date:11/27/2015)... ... November 27, 2015 , ... The men and ... nonprofit healthcare organizations in the country. They have overseen financial turnarounds, shown commitment ... advance the healthcare industry as a whole through their advocacy and professional efforts. ...
(Date:11/26/2015)... ... November 26, 2015 , ... Patients at Serenity Point ... come together on Thanksgiving Day to share the things that they are most ... Serenity Point YouTube channel, patients displayed what they wrote on index cards, describing ...
Breaking Medicine News(10 mins):